Analyst: Stem cell agency reforms fall short

by Blogburger on February 1, 2013

With little money and time left to repair its legacy, California’s controversial stem cell agency is falling short in its response to a federal committee’s recommendations for an overhaul, the committee’s chair said Thursday. The stem cell agency’s reform plan does not go far enough to fix all that has been chipping away at the agency’s credibility, said Harold Shapiro, chair of the Institute of Medicine committee hired to evaluate the agency. “There certainly is a gap between what we recommended and what they responded with,” said Shapiro, president emeritus at Princeton University. “I wish they had moved closer to our recommendations.” The committee presented sweeping recommendations in…

WN.com – Health News

by Amazon Auto Links

Comments on this entry are closed.

Previous post:

Next post: